Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Advanced Composites
LeftNav
Aerospace
LeftNav
Amorphous Metal Structures
LeftNav
Analysis and Simulation
LeftNav
Asbestos and Substitutes
LeftNav
Associations, Research Organisations and Universities
LeftNav
Automation Equipment
LeftNav
Automotive
LeftNav
Biomaterials
LeftNav
Building Materials
LeftNav
Bulk Handling and Storage
LeftNav
CFCs and Substitutes
LeftNav
Company
LeftNav
Components
LeftNav
Consultancy
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
 
News

Yale researchers map protein binding that is critical to life

Yale University : 02 February, 2006  (New Product)
A Yale School of Medicine laboratory has succeeded in mapping and describing an interaction important for cell adhesion, a process critical to life, and, when it goes awry, can lead to diseases such as cancer.
A Yale School of Medicine laboratory has succeeded in mapping and describing an interaction important for cell adhesion, a process critical to life, and, when it goes awry, can lead to diseases such as cancer.

Adhesion of a cell to neighboring cells or proteins transmits information into the cell that determines whether it should grow, divide, develop or move. Integrins are a family of adhesion proteins that are central to this communication and are present on almost every human cell.

'Mutations in integrins lead to bleeding disorders, defective immune responses and cancer,' said David Calderwood, assistant professor in the Department of Pharmacology and senior author of the study in Molecular Cell. 'Integrins regulate inflammation, vascular disease and clot formation. On cancer cells they can promote tumor metastasis.'

He said drugs that target integrins are used to control thrombosis and are in trials for the treatment of heart disease, stroke, inflammation, multiple sclerosis and cancer. 'However, a complete understanding of how integrins work is still lacking,' Calderwood said.

His lab set out to examine the interaction between integrins and filamin. Filamin functions as a larger molecule composed of two filamin molecules joined at one end to form a flexibile V-shaped structure. Mutations in the human filamin genes are linked to neurological and skeletal defects and also vascular problems.

'Our lab has succeeded in mapping the region, or domain, within filamin that binds to integrins and has shown that removing this domain drastically reduces the ability of filamin to bind integrins,' Calderwood said. His group, working in collaboration with researchers in Finland and the United Kingdom and using X-ray crystallography and nuclear magnetic resonance spectroscopy, also provided the first detailed molecular structure of the short intracellular integrin tail bound to filamin.

'We have identified key points of interaction and show that this mode of interaction is common for filamin binding to many of its other binding partners,' he said. 'Our structure also revealed two important mechanisms by which the cell can regulate the filamin-integrin interaction. This could be important for controlling integrin function and may provide a point for therapeutic intervention.'

Co-authors include Tiila Kiema and Jari Ylanne, Finland; Yatish Lad and Massimiliano Baldassarre, Yale; Pengju Jiang, Camilla Oxley, Kate Wegener, Iain Campbell from Oxford.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 NewMaterials.com
Netgains Logo